Forsiden UiO Det medisinske fakultet Institutt for helse og samfunn
print logo

2007

2007/1: Forfattere: Kittelsen SAC, Magnussen J, Anthun KS, Frischsenteret, HERO, NTNU - Norges teknisk- naturvitenskapelige universitet & SINTEF Helse (PDF)

Et ønske bak sykehusreformen av 2002 var at sykehusene skulle kjøpe inn mer tjenester fra private aktører for å stimulere til kostnads-effektivisering gjennom konkurranse (St. meld. nr. 5 (2003- 2004)). I rapporten 2007:2 omhandles forholdet mellom de regionale helseforetakene og de private leverandørene av laboratorie- og røntgentjenester i kjølvannet av sykehusreformen.

2007/2: Forfattere: Hagen TP, Iversen T, Kittelsen SAC, Institutt for helseledelse og helseøkonomi, UiO, Frischsenteret & HERO - Helseøkonomisk forskningsprogram ved Universitetet i Oslo (PDF)

2007/3: Forfattere: Harsvik T, Kjekshus LE, SINTEF Helse, Institutt for Helseledelse og helseøkonomi, HERO og HORN (PDF)

2007/4: Authors: Godager G, Iversen T, Ma CA. Institute of Health Management and Health Economics, Department of Economics, Boston University and Department of Economics, University of Oslo, Norway, and the HERO programme. (PDF)

2007/5: Author: Grepperud S, Institute of Health Management and Health Economics University of Oslo, and the HERO programme. (PDF)

2007/6: Forfatter: Godager G, Iversen T, Lurås H, Institutt for helseledelse og helseøkonomi, Universitetet i Oslo, Helse Øst Kompetanssenter for Helsetjenesteforskning (PDF)

2007/7: Author: Fauli F, Thue G, The Norwegian Medical Association, The Norwegian Quality Improvement of Laboratory Services in Primary Care (NOKLUS), and HERO, and Department of Public Health and Primary Health Care, University of Bergen. (PDF)

Health expenditure complements saving in equilibrium, and contributes to economic growth. Which in turn leads to a further increase in health investment. The picture show Chinese medical practitioners control a CT scanning of a head (Photo; Gunn Kristin Tjoflot).

2007/8: Author: Chen Y, Department of Economics, University of Oslo and HERO (PDF)

2007/9: Author: Iversen T, Health Economics Research Programme at the University of Oslo, and Institute of Health Management and Health Economics (PDF)

Chlamydia is the most common bacterial sexually transmitted infection worldwide and a major cause of morbidity – particularly among women and neonates (newborn infant). In this study the researchers  compared costs and health consequences of using point-of-care (POC) tests with current syndromic management among antenatal care attendees in sub-Saharan Africa. The erythromycin was also compared with azithromycin treatment and universal with age-based chlamydia management.

2007/10: Authors: Romoren M, Sundby J,  Hjortdahl P,  Hussein F, Steen TW, Velauthapillai M, Kristiansen IS, University of Oslo, Ministry of Health, Gaborone, Botswana, University of Oslo and University of Southern Denmark and HERO (PDF)